The present invention relates compounds that are NK-1 antagonists and that are of use in the treatment or prevention of depression, anxiety, pain, inflammation, migaine, emesis or postherpetic neuralgia.

 
Web www.patentalert.com

< Method and apparatus for relaying packets based on class of service

< Methods and apparatus for allocating, costing, and pricing organizational resources

> Temperature compensating device for APD optical receiver

> Water-absorbing agent and its production process and use
~ 00221